Community-care unit model of residential mental health rehabilitation services in Queensland, Australia: predicting outcomes of consumers 1-year post discharge.


Journal

Epidemiology and psychiatric sciences
ISSN: 2045-7979
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091

Informations de publication

Date de publication:
11 Mar 2020
Historique:
entrez: 12 3 2020
pubmed: 12 3 2020
medline: 20 3 2020
Statut: epublish

Résumé

Community care units (CCUs) are a model of residential psychiatric rehabilitation aiming to improve the independence and community functioning of people with severe and persistent mental illness. This study examined factors predicting improvement in outcomes among CCU consumers. Hierarchical regression using data from a retrospective cohort (N = 501) of all consumers admitted to five CCUs in Queensland, Australia between 2005 and 2014. The primary outcome was changed in mental health and social functioning (Health of the Nation Outcome Scale). Secondary outcomes were disability (Life Skills Profile-16), service use, accommodation instability, and involuntary treatment. Potential predictors covered service, consumer, and treatment characteristics. Group-level and individualised change were assessed between the year pre-admission and post-discharge. Where relevant and available, the reliable and clinically significant (RCS) change was assessed by comparison with a normative sample. Group-level analyses showed statistically significant improvements in mental health and social functioning, and reductions in psychiatry-related bed-days, emergency department (ED) presentations and involuntary treatment. There were no significant changes in disability or accommodation instability. A total of 54.7% of consumers demonstrated reliable improvement in mental health and social functioning, and 43.0% showed RCS improvement. The majority (60.6%) showed a reliable improvement in psychiatry-related bed-use; a minority demonstrated reliable improvement in ED presentations (12.5%). Significant predictors of improvement included variables related to the CCU care (e.g. episode duration), consumer characteristics (e.g. primary diagnosis) and treatment variables (e.g. psychiatry-related bed-days pre-admission). Higher baseline impairment in mental health and social functioning (β = 1.12) and longer episodes of CCU care (β = 1.03) increased the likelihood of RCS improvement in mental health and social functioning. CCU care was followed by reliable improvements in relevant outcomes for many consumers. Consumers with poorer mental health and social functioning, and a longer episode of CCU care were more likely to make RCS improvements in mental health and social functioning.

Identifiants

pubmed: 32157987
doi: 10.1017/S2045796020000207
pii: S2045796020000207
pmc: PMC7214525
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e109

Références

Br J Psychiatry. 2009 Nov;195(5):433-9
pubmed: 19880934
Int Rev Psychiatry. 2010;22(2):114-29
pubmed: 20504052
Disabil Rehabil. 2019 Dec;41(24):2927-2939
pubmed: 29978733
Australas Psychiatry. 2019 Apr;27(2):197-198
pubmed: 30994029
Aust Health Rev. 2017 May;41(2):139-143
pubmed: 27119964
Schizophr Res. 2004 Oct 1;70(2-3):331-42
pubmed: 15329308
Soc Psychiatry Psychiatr Epidemiol. 2013 Jun;48(6):1005-12
pubmed: 22945367
Soc Psychiatry Psychiatr Epidemiol. 2008 Jul;43(7):569-74
pubmed: 18347750
BJPsych Bull. 2016 Feb;40(1):24-8
pubmed: 26958355
Soc Psychiatry Psychiatr Epidemiol. 2014 Jan;49(1):157-67
pubmed: 23712514
J Gerontol. 1987 Nov;42(6):579-83
pubmed: 3680874
Community Ment Health J. 2011 Oct;47(5):531-41
pubmed: 20931282
Aust N Z J Psychiatry. 2007 Apr;41(4):343-50
pubmed: 17464721
Aust N Z J Psychiatry. 2012 Jul;46(7):651-8
pubmed: 22528976
Psychiatry Res. 2011 Nov 30;190(1):9-17
pubmed: 20417974
J Rehabil Res Dev. 2007;44(6):775-83
pubmed: 18075936
Aust N Z J Psychiatry. 2017 Apr;51(4):338-354
pubmed: 28118728
Int Rev Psychiatry. 2015;27(4):264-75
pubmed: 25768326
Aust N Z J Psychiatry. 2016 May;50(5):410-72
pubmed: 27106681
Am J Public Health. 2013 Oct;103(10):e89-95
pubmed: 23865662
Soc Psychiatry Psychiatr Epidemiol. 2016 Aug;51(8):1055-72
pubmed: 27465245
Soc Psychiatry Psychiatr Epidemiol. 2001 Aug;36(8):416-9
pubmed: 11766972
Soc Sci Res. 2016 Sep;59:1-12
pubmed: 27480367
J Ment Health. 2018 Apr 27;:1-9
pubmed: 29701489
J Consult Clin Psychol. 1991 Feb;59(1):12-9
pubmed: 2002127
Br J Psychiatry. 1999 May;174:404-8
pubmed: 10616605
BMC Psychiatry. 2016 Jun 02;16:179
pubmed: 27255702
BJPsych Bull. 2017 Dec;41(6):330-336
pubmed: 29234510
Aust N Z J Psychiatry. 2005 Aug;39(8):719-25
pubmed: 16050926
Front Psychiatry. 2019 Mar 20;10:147
pubmed: 30949081
Aust N Z J Psychiatry. 1995 Sep;29(3):492-9
pubmed: 8573054
Soc Psychiatry Psychiatr Epidemiol. 2007 May;42(5):355-9
pubmed: 17492405
BMC Psychiatry. 2019 Feb 4;19(1):55
pubmed: 30717713
Int J Ment Health Syst. 2012 May 28;6(1):4
pubmed: 22640939
Br J Psychiatry. 1998 Jan;172:11-8
pubmed: 9534825

Auteurs

S Parker (S)

Metro South Addiction and Mental Health Services (MSAMHS), Brisbane, Australia.
University of Queensland, School of Public Health, Herston, Australia.

U Arnautovska (U)

PA Foundation, Princess Alexandra Hospital, BrisbaneAustralia.

D Siskind (D)

Metro South Addiction and Mental Health Services (MSAMHS), Brisbane, Australia.
University of Queensland, School of Public Health, Herston, Australia.
School of Medicine, The University of Queensland, Brisbane, Australia.

F Dark (F)

Metro South Addiction and Mental Health Services (MSAMHS), Brisbane, Australia.
University of Queensland, School of Public Health, Herston, Australia.

G McKeon (G)

Metro South Addiction and Mental Health Services (MSAMHS), Brisbane, Australia.

N Korman (N)

Metro South Addiction and Mental Health Services (MSAMHS), Brisbane, Australia.

M Harris (M)

University of Queensland, School of Public Health, Herston, Australia.
Policy and Epidemiology Group, Queensland Centre for Mental Health Research, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH